Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  HYPERTENSION

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.27.1.7PMID 8591891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion.

  1995cited by this paper
• Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion.

  1995cited by this paper
• Increases in cardiac kinins as a new mechanism to protect the heart.

  1994cited by this paper
• Complement, neutrophils and free radicals: mediators of reperfusion injury.

  1994cited by this paper
• A local kallikrein-kinin system is present in rat hearts.

  1994cited by this paper
• Cardioprotection by angiotensin converting enzyme inhibitors--the experimental evidence.

  1994cited by this paper
• Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease.

  1994cited by this paper
• Complement, neutrophils and free radicals: mediators of reperfusion injury.

  1994cited by this paper
• A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.

  1993cited by this paper
• Endogenous myocardial protective (antiarrhythmic) substances.

  1993cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

  1993cited by this paper
• Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.

  1993cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

  1993cited by this paper
• Kallikrein release by vascular tissue.

  1993cited by this paper
• Reduction of Myocardial Infarct Size in Rabbits by Ramiprilat: Reversal by the Bradykinin Antagonist HOE 140

  1993cited by this paper
• Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs.

  1993cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Generation of superoxide by purified brain nitric oxide synthase.

  1992cited by this paper
• Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size.

  1992cited by this paper
• Role of Prostaglandins in the Cardiovascular Effects of Bradykinin and Angiotensin‐Converting Enzyme Inhibitors

  1992cited by this paper
• Effects of Early Angiotensin-Converting Enzyme Inhibition in a Pig Model of Myocardial Ischemia and Reperfusion

  1992cited by this paper
• Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.

  1992cited by this paper
• ACE-inhibition, kinins, and vascular PGI2 synthesis.

  1992cited by this paper
• Role of Oxygen‐Derived Free Radicals in Myocardial Edema and Ischemia in Coronary Microvascular Embolization

  1991cited by this paper
• Ramiprilat Enhances Endothelial Autacoid Formation by Inhibiting Breakdown of Endothelium‐Derived Bradykinin

  1991cited by this paper
• Local Hormonal Factors (Intracrine, Autocrine, and Paracrine) in Hypertension

  1991cited by this paper
• Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist.

  1990cited by this paper
• Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.

  1990cited by this paper
• Basic pharmacology of ACE-inhibitors with respect to ischaemic heart disease: prostaglandins and bradykinin.

  1990cited by this paper
• Kinin Antagonist Reverses Converting Enzyme Inhibitor‐Stimulated Vascular Prostaglandin I2 Synthesis

  1989cited by this paper
• Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril

  1989cited by this paper
• The role of the neutrophil and free radicals in ischemic myocardial injury.

  1989cited by this paper
• Sustained Limitation by Superoxide Dismutase of Canine Myocardial Injury Due to Regional Ischemia Followed by Reperfusion

  1988cited by this paper
• Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist

  1988cited by this paper
• Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivo.

  1988cited by this paper
• Reperfusion-induced arrhythmias: mechanisms of protection by glucose and mannitol.

  1988cited by this paper
• Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.

  1986cited by this paper
• Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.

  1986cited by this paper
• Limitation of Experimental Infarct Size by an Angiotensin‐converting Enzyme Inhibitor

  1982cited by this paper

• Goat Milk Protein-Derived ACE Inhibitory Peptide SLPQ Exerts Hypertension Alleviation Effects Partially by Regulating the Inflammatory Stress of Endothelial Cells

  2024cites this paper
• Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease

  2023cites this paper
• ACE inhibitory activities of two peptides derived from Volutharpa ampullacea perryi hydrolysate and their protective effects on H2O2 induced HUVECs injury.

  2022cites this paper
• Modulation of connective tissue growth factor and activin receptor 2b function in cardiac hypertrophy and fibrosis

  2019cites this paper
• Exposure to diisononyl phthalate induced an increase in blood pressure through activation of the ACE/ AT1R axis and inhibition of NO production.

  2019cites this paper
• β-1 adrenoceptors and AT1 receptors may not be involved in catecholamine-induced lethal arrhythmias 1.

  2019cites this paper
• Draft 1 Both β1 adrenoceptors and AT 1 receptors may not be involved in the catecholamine-induced lethal arrhythmias

  2018influential citation
• PROTECTIVE EFFECTS OF IVABRADINE (ALONE AND COMBINED WITH ATENOLOL OR ENALAPRIL) ON EXPERIMENTALLY-INDUCED ACUTE MYOCARDIAL INFARCTION IN ALBINO RATS

  2017cites this paper
• transgenic rats hypoxia-reoxygenation in renin-angiotensinogen Decreased susceptibility of cardiac function to

  2016cites this paper
• Intravenous Administration of Lycopene, a Tomato Extract, Protects against Myocardial Ischemia-Reperfusion Injury

  2016cites this paper
• The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on Pressure Overload-Induced Cardiac Remodeling in Rats and the Endothelial Mechanisms Based on PGI2

  2015cites this paper
• Effects of the AT1 receptor blocker candesartan on myocardial ischemia/reperfusion in isolated rat hearts.

  2014cites this paper
• The influence of age and type 2 diabetes on cardioprotective interventions against myocardial ischaemia-reperfusion injury.

  2013cites this paper
• KLK1 A1789G gene polymorphism and the risk of coronary artery stenosis in the Chinese population.

  2013cites this paper
• Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury.

  2013cites this paper
• Cardioprotection by ACE Inhibitors in Myocardial Ischaemia/Reperfusion

  2012cites this paper
• Vasoactive Molecules and the Kidney

  2012cites this paper
• The kallikrein-kinin system in diabetic nephropathy

  2012cites this paper
• Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury

  2012cites this paper
• Influence of ramiprilat and losartan on ischemia reperfusion injury in rat hearts

  2012cites this paper
• Impact of kinins in the treatment of cardiovascular diseases.

  2012cites this paper
• Modulation of hemodynamics, endogenous antioxidant enzymes, and pathophysiological changes by Angiotensin-converting enzyme inhibitors in pressure-overload rats.

  2011cites this paper
• Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice

  2011cites this paper
• Effects of protein coding polymorphisms in the kallikrein 1 gene on baseline blood pressure and antihypertensive response to irbesartan in Chinese hypertensive patients

  2011cites this paper
• Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.

  2011cites this paper
• Hypertensive Encephalopathy and Acute Blood Pressure Management After Hemorrhagic Stroke

  2011cites this paper
• Evaluation of the effects of losartan on a random pattern skin flap model in rats.

  2011cites this paper
• The kallikrein-kinin system as a regulator of cardiovascular and renal function.

  2011cites this paper
• Additive Effect of TAK-491, a New Angiotensin Receptor Blocker, and Pioglitazone, in Reducing Myocardial Infarct Size

  2010cites this paper
• Cardioprotective properties of bradykinin: role of the B2 receptor

  2010cites this paper
• Renin angiotensin system and cardiovascular disease

  2010cites this paper
• A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept

  2010cites this paper
• Chloride Channel 2 and Protein Kinase C Epsilon Protein Module in Ischemic Preconditioning of Rabbit Cardiomyocytes

  2010cites this paper
• Kinins and Cardiovascular Disease

  2009cites this paper
• Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in rats

  2009cites this paper
• The kallikrein-kinin system in health and in diseases of the kidney.

  2009cites this paper
• The Effect of Enalapril on Skin Flap Viability is Independent of Angiotensin II AT1 Receptors

  2009cites this paper
• The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury

  2009cites this paper
• Does Olea africana protect the heart against ischemiareperfusion injury

  2009cites this paper
• CARDIOPROTECTION AND KALLIKREIN–KININ SYSTEM IN ACUTE MYOCARDIAL ISCHAEMIA IN MICE

  2008cites this paper
• Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets.

  2008cites this paper
• Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors

  2008cites this paper
• Metabolism of Bradykinin by Peptidases in Health and Disease

  2007cites this paper
• Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury

  2007cites this paper
• JPET # 124859 1 Tissue kallikrein is involved in the cardioprotective effect of AT 1-receptor blockade in acute myocardial ischemia

  2007influential citation
• Tissue Kallikrein Is Involved in the Cardioprotective Effect of AT1-Receptor Blockade in Acute Myocardial Ischemia

  2007cites this paper
• Nitric oxide and cardiac function.

  2007cites this paper
• Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat.

  2007cites this paper
• Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury.

  2006cites this paper
• Kallidin‐like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart

  2006cites this paper
• Ligand triggers of classical preconditioning and postconditioning.

  2006cites this paper
• Role of p90 Ribosomal S6 Kinase–Mediated Prorenin-Converting Enzyme in Ischemic and Diabetic Myocardium

  2006cites this paper
• Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process.

  2005cites this paper
• Angiotensin II type 1 receptor antagonist protects ventricular and coronary endothelial function after 24-hour heart preservation.

  2005cites this paper
• Protective effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemia-reperfusion-induced apoptotic cell death.

  2005cites this paper
• Effects of ACE Inhibition and AT1 Receptor Blockade on Cardiac Ischaemia-Reperfusion Induced Mortality and Cardiac Markers in Rats

  2005cites this paper
• Reduction of ischemia--reperfusion induced myocardial infarct size in rats by caffeic acid phenethyl ester (CAPE).

  2004cites this paper
• Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction.

  2004cites this paper
• The Role of Nitric Oxide in Heart Failure

  2004cites this paper
• Pharmacological therapy for myocardial reperfusion injury.

  2004cites this paper
• Collagen production in cardiac fibroblasts during inhibition of angiotensin-converting enzyme and aminopeptidases

  2004cites this paper
• New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.

  2004cites this paper
• 3,4,5,6-Tetrahydroxyxanthone Protects Against Myocardial Ischemia-Reperfusion Injury in Rats

  2004cites this paper
• Nitric Oxide and Cardiovascular Protection

  2004cites this paper
• Can the premises of the spasm of resistance vessel concept permit improvement in the treatment and prevention of ischemic heart disease?

  2003cites this paper
• Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.

  2003cites this paper
• Nitric oxide- and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and reperfusion injury.

  2003cites this paper
• Reperfusion-Induced Arrhythmias Are Suppressed by Inhibition of the Angiotensin II Type 1 Receptor

  2003cites this paper
• Sepiapterin reduces postischemic injury in the rat heart

  2003cites this paper
• The role of endogenous angiotensin II in ischaemia, reperfusion and preconditioning of the isolated rat heart

  2003cites this paper
• Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction.

  2003cites this paper
• Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

  2003cites this paper
• Immunohistochemical Distributions of the Tissue Kallikrein‐Kinin System in Ischemic and Non‐Ischemic Mouse Heart

  2003cites this paper
• Role of AT1 Receptor Blockade in Reperfused Myocardial Infarction

  2003cites this paper
• Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.

  2002cites this paper
• Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykinin

  2002cites this paper
• Myocardial ischemia–reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin

  2002cites this paper
• A study of the effects of angiotensin II on the atrial electrophysiological characteristics in normal dogs

  2002cites this paper
• Kinins and kinin receptors in the pathogenesis of heart failure

  2002cites this paper
• Angiotensin II subtype 1 (AT1) receptors contribute to ischemic contracture and regulate chemomechanical energy transduction in isolated transgenic rat (αMHC‐hAT1)594–17 hearts

  2002cites this paper
• Nitric Oxide and Cardioprotection During Ischemia-Reperfusion

  2002cites this paper
• Effect of ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists on Endothelial NO Synthase Knockout Mice With Heart Failure

  2002cites this paper
• Efficacy of Angiotensin II Type 1 Receptor Blockade on Reperfusion-Induced Arrhythmias and Mortality Early After Myocardial Infarction Is Increased in Transgenic Rats With Cardiac Angiotensin II Type 1 Overexpression

  2002influential citation
• Decreased susceptibility of cardiac function to hypoxia-reoxygenation in renin-angiotensinogen transgenic rats.

  2002cites this paper
• Angiotensin and its AT2 receptor: new insights into an old system.

  2001cites this paper
• Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research.

  2001cites this paper
• Influence of the Angiotensin II AT1 Receptor Antagonist on Reperfusion Injury in Rat Myocardial Ischemia Model

  2001cites this paper
• Crosstalk between ACE inhibitors, B2 kinin receptor and nitric oxide in endothelial cells

  2001cites this paper
• Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells.

  2001cites this paper
• Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on DNA and Collagen Synthesis in Rat Cardiac Fibroblasts

  2001cites this paper
• Anti‐Ischemic Potential of Drugs related to the Renin‐Angiotensin System

  2001cites this paper
• Effects of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Type 1 Receptor Antagonist in Deoxycorticosterone Acetate–Salt Hypertensive Mice Lacking Ren-2 Gene

  2001cites this paper
• The involvement of bradykinin in adrenaline-induced pulmonary edema in rats.

  2001cites this paper
• Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction.

  2001cites this paper
• Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury.

  2001cites this paper
• Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion

  2001cites this paper
• Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKCε Proteins and cGMP

  2000cites this paper
• Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.

  2000cites this paper
• The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

  2000cites this paper
• Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.

  2000cites this paper